货号:A759947
同义名:
顺-二十碳五烯酸乙酯
/ EPA ethyl ester; Ethyl eicosapentaenoate
Eicosapentaenoic acid ethyl ester is an omega-3 fatty acid agent.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Eicosapentaenoic acid ethyl ester is an omega-3 fatty acid agent. The enhanced contractile response by phenylephrine in diabetic mice was not altered by the administration of EPA-E (10 mg/day). In addition, the direct administration of EPA-E metabolites such as EPA, docosahexaenoic acid, and docosapentaenoic acid led to vasodilation in the aortic rings of C57BL/6 J mice. Chronic EPA-E administration prevented the development of endothelial dysfunction in KKAy mice, partly via the direct action of EPA-E metabolites on the aorta[3]. Oral administration of EPA-E ameliorated skin barrier dysfunction and pruritus in AD mice. In the SC of AD mice, covalently bound Cer were markedly diminished[4]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01002118 | Cardiovascular Disease | Not Applicable | Terminated(Unable to recruit e... 展开 >>ligible subjects; no data analyzed) 收起 << | - | United States, Iowa ... 展开 >> University of Iowa Iowa City, Iowa, United States, 52242 收起 << |
NCT00504309 | Hypertriglyceridemia | Not Applicable | Completed | - | United States, Pennsylvania ... 展开 >> Penn State University General Clinical Research Center University Park, Pennsylvania, United States, 16802 收起 << |
NCT01056133 | Non-alcoholic Fatty Liver Dise... 展开 >>ase Non-alcoholic Steatohepatitis 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University Health Network, Toronto General Hospital Toronto, Ontario, Canada, M5G 1Z5 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.03mL 0.61mL 0.30mL |
15.13mL 3.03mL 1.51mL |
30.26mL 6.05mL 3.03mL |
CAS号 | 86227-47-6 |
分子式 | C22H34O2 |
分子量 | 330.5 |
SMILES Code | O=C(OCC)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC |
MDL No. | MFCD00673476 |
别名 | 顺-二十碳五烯酸乙酯 ;EPA ethyl ester; Ethyl eicosapentaenoate; Icosapent ethyl; AMR101 |
运输 | 蓝冰 |
InChI Key | SSQPWTVBQMWLSZ-AAQCHOMXSA-N |
Pubchem ID | 9831415 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 |
溶解方案 |
DMSO: 105 mg/mL(317.7 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 无水乙醇: 50 mg/mL(151.28 mM),配合低频超声助溶,注意:无水乙醇开封后,易挥发,也会吸收空气中的水分,导致溶解能力下降,请避免使用开封较久的乙醇 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|